100
Participants
Start Date
March 24, 2022
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2024
Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature
Implant and initial programming of the Infinity DBS system for this cohort are conducted according to the sites standard of care. After initial programming, all follow-up programming for the first 3 months is conducted in-clinic (not using the Virtual Clinic feature).
Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature (virtual clinic and in-clinic sessions)
Implant and initial programming of the Infinity DBS system for this cohort are conducted according to the sites standard of care. After initial programming, all follow-up programming for the first 3 months is conducted using Virtual Clinic or in-clinic as appropriate.
Thomas Jefferson Department of Neurosurgery, Philadelphia
Hospital Universitario de la Princesa, Madrid
University of Miami Hospital, Miami
Medizinische Einrichtungen der Universität Düsseldorf, Düsseldorf
Hospital Virgen de Rocio, Seville
Ohio State Medical, Columbus
The Cleveland Clinic Foundation, Cleveland
Indiana University, Indianapolis
UNIVERSITATSMEDIZIN der Johannes Gutenberg-Universität Mainz, Mainz
Rush University Medical Center, Chicago
Universitäts Klinikum Tübingen, Tübingen
Texas Movement Disorder Specialist, Georgetown
University of Arizona Health Sciences Center, Tucson
University of California at Davis, Sacramento
Beth Israel Deaconess Medical Center, Boston
Dartmouth Hitchcock Medical Center, Lebanon
Hospital Universitari Germans Trias I Pujol, Badalona
Queen Elizabeth University Hospital, Glasgow
Lead Sponsor
Abbott Medical Devices
INDUSTRY